MD Anderson, Taiho Pharmaceutical Announce Collaboration to Accelerate Development of Novel Therapies for Brain Metastasis
September 25, 2020
September 25, 2020
HOUSTON, Texas, Sept. 25 (TNSRes) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Sept. 24:
The University of Texas MD Anderson Cancer Center and Taiho Pharmaceutical Co., Ltd., today announced a three-year strategic collaboration to accelerate the development of treatments for significant unmet medical needs in oncology, including patients with brain metastases and those with cancers refractory to available therapies.
Th . . .
The University of Texas MD Anderson Cancer Center and Taiho Pharmaceutical Co., Ltd., today announced a three-year strategic collaboration to accelerate the development of treatments for significant unmet medical needs in oncology, including patients with brain metastases and those with cancers refractory to available therapies.
Th . . .